Literature DB >> 19718698

Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium.

Magdalena M Mahlstedt1, David Anderson, James S Sharp, Roger McGilvray, Maria D Barbadillo Muñoz, Lee D Buttery, Morgan R Alexander, Felicity R A J Rose, Chris Denning.   

Abstract

Realizing the potential clinical and industrial applications of human embryonic stem cells (hESCs) is limited by the need for costly, labile, or undefined growth substrates. Here we demonstrate that trypsin passaging of the hESC lines, HUES7 and NOTT1, on oxygen plasma etched tissue culture polystyrene (PE-TCPS) in conditioned medium is compatible with pluripotency. This synthetic culture surface is stable at room temperature for at least a year and is readily prepared by placing polystyrene substrates in a radio frequency oxygen plasma generator for 5 min. Modification of the polystyrene surface chemistry by plasma etching was confirmed by X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (ToF-SIMS), which identified elemental and molecular changes as a result of the treatment. Pluripotency of hESCs cultured on PE-TCPS was gauged by consistent proliferation during serial passage, expression of stem cell markers (OCT4, TRA1-60, and SSEA-4), stable karyotype and multi-germlayer differentiation in vitro, including to pharmacologically responsive cardiomyocytes. Generation of cost-effective, easy-to-handle synthetic, defined, stable surfaces for hESC culture will expedite stem cell use in biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19718698     DOI: 10.1002/bit.22520

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  15 in total

1.  Developmental Competence of Buffalo (Bubalus bubalis) Pluripotent Embryonic Stem Cells Over Different Homologous Feeder Layers and the Comparative Evaluation with Various Extracellular Matrices.

Authors:  Manjinder Sharma; Pawan K Dubey; Rajesh Kumar; Amar Nath; G Sai Kumar; G Taru Sharma
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

Review 2.  Substrates for clinical applicability of stem cells.

Authors:  Sanjar Enam; Sha Jin
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.

Authors:  Yue Shao; Jianming Sang; Jianping Fu
Journal:  Biomaterials       Date:  2015-02-21       Impact factor: 12.479

Review 4.  Engineering biomaterials for feeder-free maintenance of human pluripotent stem cells.

Authors:  Kisuk Yang; Joan Lee; Seung-Woo Cho
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

Review 5.  High-throughput approaches for screening and analysis of cell behaviors.

Authors:  Jungmok Seo; Jung-Youn Shin; Jeroen Leijten; Oju Jeon; Gulden Camci-Unal; Anna D Dikina; Katelyn Brinegar; Amir M Ghaemmaghami; Eben Alsberg; Ali Khademhosseini
Journal:  Biomaterials       Date:  2017-06-21       Impact factor: 12.479

Review 6.  In vitro uses of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Elena Matsa; Chris Denning
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

Review 7.  Materials for stem cell factories of the future.

Authors:  Adam D Celiz; James G W Smith; Robert Langer; Daniel G Anderson; David A Winkler; David A Barrett; Martyn C Davies; Lorraine E Young; Chris Denning; Morgan R Alexander
Journal:  Nat Mater       Date:  2014-06       Impact factor: 43.841

8.  A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells.

Authors:  Sha Jin; Huantong Yao; Jennifer L Weber; Zara K Melkoumian; Kaiming Ye
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.

Authors:  Elena Matsa; James E Dixon; Christopher Medway; Orestis Georgiou; Minal J Patel; Kevin Morgan; Paul J Kemp; Andrew Staniforth; Ian Mellor; Chris Denning
Journal:  Eur Heart J       Date:  2013-03-06       Impact factor: 29.983

Review 10.  Current status of drug screening and disease modelling in human pluripotent stem cells.

Authors:  Divya Rajamohan; Elena Matsa; Spandan Kalra; James Crutchley; Asha Patel; Vinoj George; Chris Denning
Journal:  Bioessays       Date:  2012-08-08       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.